Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1180 | 2701 | 32.6 | 74% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MEDULLARY THYROID CARCINOMA | Author keyword | 427 | 64% | 15% | 418 |
2 | RET PROTO ONCOGENE | Author keyword | 154 | 69% | 5% | 132 |
3 | MEDULLARY THYROID CANCER | Author keyword | 76 | 50% | 4% | 109 |
4 | MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 | Author keyword | 75 | 71% | 2% | 60 |
5 | C CELL HYPERPLASIA | Author keyword | 63 | 78% | 2% | 42 |
6 | RET MUTATION | Author keyword | 62 | 92% | 1% | 24 |
7 | PROPHYLACTIC THYROIDECTOMY | Author keyword | 61 | 95% | 1% | 20 |
8 | RET PROTOONCOGENE | Author keyword | 57 | 69% | 2% | 49 |
9 | MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B | Author keyword | 55 | 92% | 1% | 22 |
10 | MULTIPLE ENDOCRINE NEOPLASIA | Author keyword | 46 | 36% | 4% | 104 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MEN 2A | 637 | 91% | 10% | 264 |
2 | FMTC | 315 | 88% | 5% | 148 |
3 | PROPHYLACTIC THYROIDECTOMY | 292 | 88% | 5% | 136 |
4 | MEDULLARY THYROID CARCINOMA | 259 | 43% | 17% | 460 |
5 | SERUM CALCITONIN | 239 | 78% | 6% | 156 |
6 | C CELL HYPERPLASIA | 207 | 78% | 5% | 135 |
7 | PROTOONCOGENE MUTATIONS | 163 | 88% | 3% | 78 |
8 | ROUTINE MEASUREMENT | 141 | 68% | 5% | 123 |
9 | RET PROTOONCOGENE | 132 | 31% | 13% | 351 |
10 | NEOPLASIA TYPE 2A | 107 | 67% | 4% | 96 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association | 2009 | 423 | 328 | 74% |
RET revisited: expanding the oncogenic portfolio | 2014 | 35 | 187 | 44% |
Guidelines for diagnosis and therapy of MEN type 1 and type 2 | 2001 | 836 | 132 | 43% |
Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma: An Update | 2013 | 30 | 142 | 74% |
Medullary thyroid cancer diagnosis: An appraisal | 2014 | 5 | 79 | 91% |
Medullary thyroid carcinoma | 2004 | 133 | 49 | 88% |
RET proto-oncogene in the development of human cancer | 1999 | 182 | 113 | 78% |
Update on the Cytologic and Molecular Features of Medullary Thyroid Carcinoma | 2014 | 7 | 86 | 65% |
Genotype-phenotype correlation in multiple endocrine neoplasia type 2 | 2012 | 13 | 33 | 100% |
Medullary thyroid carcinoma (MTC) and RET proto-oncogene: Mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form | 2013 | 11 | 94 | 94% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GEN VISCERAL VASC SURG | 7 | 13% | 1.8% | 49 |
2 | CHARLIE HAYS CANC | 6 | 100% | 0.1% | 4 |
3 | ONCOL UROL SURG | 3 | 100% | 0.1% | 3 |
4 | PLA HOSP 117 | 3 | 100% | 0.1% | 3 |
5 | HIGH TECHNOL STUDY ENVIRONM DAMAGE ENDOCRINE | 3 | 31% | 0.3% | 8 |
6 | UMR 5641 | 3 | 29% | 0.3% | 8 |
7 | UNIDAD GENET MED DIAGNOST PRENATAL | 3 | 35% | 0.2% | 6 |
8 | HUMAN CANC GENET GRP | 3 | 14% | 0.6% | 17 |
9 | AMBISEN | 3 | 24% | 0.3% | 9 |
10 | SECT ENDOCRINOL DIABETOL | 2 | 23% | 0.3% | 9 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000137478 | ANAPLASTIC THYROID CANCER//ANAPLASTIC THYROID CARCINOMA//LENVATINIB |
2 | 0.0000107108 | C CELLS//TT CELLS//CALCITONIN SECRETION |
3 | 0.0000102548 | ENDOCRINE SURG S//ACHAETE SCUTE COMPLEX LIKE 1//CLIN SCI H4 750 |
4 | 0.0000073915 | RET PTC//PAPILLARY THYROID CARCINOMA//HBME 1 |
5 | 0.0000071817 | TC 99M V DMSA//BIOPHYS RADIOPHARMACEUT//TC 99M VDMSA |
6 | 0.0000067977 | SOLID CELL NESTS//THYROID METASTASIS//ULTIMOBRANCHIAL BODY |
7 | 0.0000067154 | PARATHYROID CARCINOMA//MENIN//MEN1 |
8 | 0.0000064065 | GDNF//GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR//NEURTURIN |
9 | 0.0000060872 | UNIT ENVIRONM HLTH SCI//UNITS ENVIRONM HLTH SCI//REACTIVE POLYESTER |
10 | 0.0000056833 | HIRSCHSPRUNG DISEASE//INTESTINAL NEURONAL DYSPLASIA//AGANGLIONOSIS |